Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Other Non Operating Income (2021 - 2025)

PAVmed has reported Other Non Operating Income over the past 5 years, most recently at -$58000.0 for Q4 2025.

  • Quarterly results put Other Non Operating Income at -$58000.0 for Q4 2025, up 96.2% from a year ago — trailing twelve months through Sep 2025 was -$1.5 million (changed N/A YoY), and the annual figure for FY2024 was -$2.5 million, up 75.78%.
  • Other Non Operating Income for Q4 2025 was -$58000.0 at PAVmed, down from $58000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for PAVM hit a ceiling of $5.4 million in Q3 2021 and a floor of -$6.6 million in Q3 2022.
  • Median Other Non Operating Income over the past 5 years was -$58000.0 (2025), compared with a mean of -$1.1 million.
  • Biggest five-year swings in Other Non Operating Income: tumbled 90750.0% in 2023 and later soared 180.38% in 2024.
  • PAVmed's Other Non Operating Income stood at $5.4 million in 2021, then plummeted by 99.47% to $29000.0 in 2022, then crashed by 3634.48% to -$1.0 million in 2023, then plummeted by 48.88% to -$1.5 million in 2024, then surged by 96.2% to -$58000.0 in 2025.
  • The last three reported values for Other Non Operating Income were -$58000.0 (Q4 2025), $58000.0 (Q1 2025), and -$1.5 million (Q4 2024) per Business Quant data.